 | 1 | AGIOS PHARMACEUTICALS INC. |  | 1002.04% | 205.0 |  |
 | 2 | Ovid Therapeutics Inc. |  | 665.35% | 348.0 |  |
 | 3 | OMEROS CORP |  | 506.44% | 316.0 |  |
![]() | 4 | SYBLEU Inc |  | 413.50% | 0.0 |  |
 | 5 | uniQure N.V. |  | 374.50% | 179.0 |  |
 | 6 | SIGA TECHNOLOGIES INC |  | 371.34% | -4.0 |  |
 | 7 | CORCEPT THERAPEUTICS INC |  | 368.40% | -2.0 |  |
 | 8 | REGENERON PHARMACEUTICALS INC. |  | 332.20% | 0.0 |  |
![]() | 9 | Kaya Holdings Inc. |  | 326.44% | 343.0 |  |
 | 10 | Atea Pharmaceuticals Inc. |  | 304.68% | 44.0 |  |
 | 11 | CATALYST PHARMACEUTICALS INC. |  | 288.34% | -10.0 |  |
 | 12 | INTEGRATED BIOPHARMA INC |  | 264.33% | 33.0 |  |
 | 13 | VERTEX PHARMACEUTICALS INC MA |  | 248.02% | -6.0 |  |
 | 14 | Xencor Inc |  | 241.62% | 48.0 |  |
 | 15 | BIODELIVERY SCIENCES INTERNATIONAL INC |  | 238.91% | 28.0 |  |
 | 16 | XOMA Corp |  | 230.28% | 3.0 |  |
 | 17 | PROCYON CORP |  | 229.95% | 5.0 |  |
 | 18 | Merck & Co. Inc. |  | 226.21% | 3.0 |  |
 | 19 | Syndax Pharmaceuticals Inc |  | 224.26% | 105.0 |  |
 | 20 | ABBOTT LABORATORIES |  | 222.35% | -7.0 |  |
 | 21 | Organon & Co. |  | 219.56% | 0.0 |  |
 | 22 | AbCellera Biologics Inc. |  | 217.44% | 0.0 |  |
 | 23 | Organogenesis Holdings Inc. |  | 202.19% | 28.0 |  |
 | 24 | Vanda Pharmaceuticals Inc. |  | 201.91% | -8.0 |  |
 | 25 | China Health Industries Holdings Inc. |  | 197.58% | -10.0 |  |
 | 26 | UNITED THERAPEUTICS Corp |  | 196.53% | -14.0 |  |
 | 27 | VERU INC. |  | 193.67% | 169.0 |  |
 | 28 | AbbVie Inc. |  | 186.86% | -8.0 |  |
 | 29 | eFFECTOR Therapeutics Inc. |  | 183.10% | 0.0 |  |
 | 30 | ORAMED PHARMACEUTICALS INC. |  | 181.59% | 107.0 |  |
![]() | 31 | Rebus Holdings Inc. |  | 168.31% | 324.0 |  |
 | 32 | NATURES SUNSHINE PRODUCTS INC |  | 168.20% | -6.0 |  |
 | 33 | Amphastar Pharmaceuticals Inc. |  | 164.56% | 8.0 |  |
 | 34 | Jazz Pharmaceuticals plc |  | 164.17% | -25.0 |  |
 | 35 | XBiotech Inc. |  | 161.62% | -18.0 |  |
 | 36 | Lipocine Inc. |  | 160.00% | 290.0 |  |
 | 37 | Lifevantage Corp |  | 153.75% | -23.0 |  |
 | 38 | Zomedica Corp. |  | 151.08% | 0.0 |  |
![]() | 39 | Tyra Biosciences Inc. |  | 144.49% | 0.0 |  |
![]() | 40 | Design Therapeutics Inc. |  | 137.98% | 0.0 |  |
 | 41 | ANAPTYSBIO INC |  | 137.80% | -18.0 |  |
 | 42 | Janux Therapeutics Inc. |  | 137.17% | 0.0 |  |
 | 43 | Thorne Healthtech Inc. |  | 136.01% | 0.0 |  |
 | 44 | OPIANT PHARMACEUTICALS INC. |  | 135.47% | 26.0 |  |
![]() | 45 | EQRx Inc. |  | 129.66% | 0.0 |  |
 | 46 | LIGAND PHARMACEUTICALS INC |  | 127.96% | 27.0 |  |
 | 47 | Emergent BioSolutions Inc. |  | 127.33% | -9.0 |  |
![]() | 48 | Theseus Pharmaceuticals Inc. |  | 125.44% | 0.0 |  |
![]() | 49 | REVELATION BIOSCIENCES INC. |  | 124.46% | 0.0 |  |
 | 50 | PFIZER INC |  | 121.44% | 10.0 |  |
 | 51 | Royalty Pharma plc |  | 121.10% | -20.0 |  |
 | 52 | Sesen Bio Inc. |  | 121.06% | 120.0 |  |
 | 53 | MARAVAI LIFESCIENCES HOLDINGS INC. |  | 116.80% | 0.0 |  |
![]() | 54 | GELESIS HOLDINGS INC. |  | 116.44% | 0.0 |  |
 | 55 | BIOMARIN PHARMACEUTICAL INC |  | 116.33% | -44.0 |  |
![]() | 56 | Nuvation Bio Inc. |  | 114.70% | 0.0 |  |
 | 57 | Zoetis Inc. |  | 113.46% | 0.0 |  |
 | 58 | MEDICINOVA INC |  | 111.65% | 29.0 |  |
![]() | 59 | Aerovate Therapeutics Inc. |  | 108.03% | 0.0 |  |
 | 60 | OPKO HEALTH INC. |  | 107.76% | -18.0 |  |
 | 61 | CASSAVA SCIENCES INC |  | 105.72% | -34.0 |  |
 | 62 | AMARIN CORP PLC\UK |  | 104.18% | -7.0 |  |
 | 63 | Catalent Inc. |  | 103.46% | 4.0 |  |
 | 64 | Endo International plc |  | 103.18% | -46.0 |  |
 | 65 | Harmony Biosciences Holdings Inc. |  | 101.60% | 60.0 |  |
 | 66 | Arcus Biosciences Inc. |  | 97.12% | 42.0 |  |
![]() | 67 | PARDES BIOSCIENCES INC. |  | 96.08% | 0.0 |  |
 | 68 | EAGLE PHARMACEUTICALS INC. |  | 96.00% | -43.0 |  |
 | 69 | Xenon Pharmaceuticals Inc. |  | 95.89% | 5.0 |  |
![]() | 70 | ATOSSA THERAPEUTICS INC. |  | 94.59% | 144.0 |  |
 | 71 | COLLEGIUM PHARMACEUTICAL INC |  | 86.96% | 13.0 |  |
 | 72 | DICE Therapeutics Inc. |  | 85.87% | 0.0 |  |
 | 73 | SUPERNUS PHARMACEUTICALS INC. |  | 85.80% | -29.0 |  |
 | 74 | Edgewise Therapeutics Inc. |  | 85.76% | 0.0 |  |
 | 75 | ALIMERA SCIENCES INC |  | 84.77% | 0.0 |  |
 | 76 | ELI LILLY & Co |  | 83.89% | -5.0 |  |
![]() | 77 | Nuvalent Inc. |  | 82.58% | 0.0 |  |
![]() | 78 | Greenwich LifeSciences Inc. |  | 79.40% | -50.0 |  |
![]() | 79 | Entrada Therapeutics Inc. |  | 77.26% | 0.0 |  |
 | 80 | BRISTOL MYERS SQUIBB CO |  | 75.79% | 31.0 |  |
![]() | 81 | Lantern Pharma Inc. |  | 74.77% | 48.0 |  |
 | 82 | PHIBRO ANIMAL HEALTH CORP |  | 71.16% | 15.0 |  |
 | 83 | Shattuck Labs Inc. |  | 70.91% | -30.0 |  |
 | 84 | Alkermes plc. |  | 69.71% | 0.0 |  |
![]() | 85 | POINT Biopharma Global Inc. |  | 69.57% | 0.0 |  |
 | 86 | KalVista Pharmaceuticals Inc. |  | 66.99% | 61.0 |  |
![]() | 87 | ESSA Pharma Inc. |  | 63.24% | 41.0 |  |
 | 88 | Eton Pharmaceuticals Inc. |  | 61.42% | 263.0 |  |
 | 89 | PERRIGO Co plc |  | 59.33% | -17.0 |  |
![]() | 90 | PMV Pharmaceuticals Inc. |  | 58.89% | -56.0 |  |
 | 91 | Avid Bioservices Inc. |  | 57.81% | 22.0 |  |
 | 92 | Pacira BioSciences Inc. |  | 56.93% | -56.0 |  |
 | 93 | IDEAYA Biosciences Inc. |  | 55.58% | 2.0 |  |
![]() | 94 | Imago BioSciences Inc. |  | 54.75% | 0.0 |  |
 | 95 | CUMBERLAND PHARMACEUTICALS INC |  | 51.04% | 0.0 |  |
![]() | 96 | Chemomab Therapeutics Ltd. |  | 50.42% | 288.0 |  |
 | 97 | Moleculin Biotech Inc. |  | 50.04% | 185.0 |  |
 | 98 | ENANTA PHARMACEUTICALS INC |  | 48.59% | -65.0 |  |
 | 99 | VistaGen Therapeutics Inc. |  | 45.53% | 291.0 |  |
![]() | 100 | Eledon Pharmaceuticals Inc. |  | 45.51% | 0.0 |  |
 | 101 | OCULAR THERAPEUTIX INC |  | 43.63% | 178.0 |  |
 | 102 | Adicet Bio Inc. |  | 43.59% | 33.0 |  |
 | 103 | Tango Therapeutics Inc. |  | 43.08% | 0.0 |  |
 | 104 | Schrodinger Inc. |  | 42.17% | 0.0 |  |
 | 105 | Elanco Animal Health Inc |  | 41.97% | -24.0 |  |
 | 106 | ANI PHARMACEUTICALS INC |  | 40.30% | -7.0 |  |
 | 107 | Immuneering Corp |  | 39.82% | 0.0 |  |
![]() | 108 | Context Therapeutics Inc. |  | 39.18% | 0.0 |  |
 | 109 | Assertio Holdings Inc. |  | 39.03% | 18.0 |  |
![]() | 110 | Synthetic Biologics Inc. |  | 37.23% | 250.0 |  |
![]() | 111 | Vaccitech plc |  | 36.32% | 0.0 |  |
![]() | 112 | Indaptus Therapeutics Inc. |  | 36.16% | 0.0 |  |
 | 113 | RIGEL PHARMACEUTICALS INC |  | 35.71% | 42.0 |  |
 | 114 | BICYCLE THERAPEUTICS plc |  | 35.61% | 69.0 |  |
 | 115 | Viatris Inc |  | 34.96% | -24.0 |  |
 | 116 | ALBIREO PHARMA INC. |  | 34.88% | 92.0 |  |
![]() | 117 | Cyteir Therapeutics Inc. |  | 34.39% | 0.0 |  |
 | 118 | TEVA PHARMACEUTICAL INDUSTRIES LTD |  | 32.25% | 4.0 |  |
 | 119 | IONIS PHARMACEUTICALS INC | | 31.87% | 26.0 |  |
 | 120 | ALX ONCOLOGY HOLDINGS INC | | 30.45% | -83.0 |  |
![]() | 121 | Biomea Fusion Inc. | | 28.95% | 0.0 |  |
 | 122 | iBio Inc. | | 27.17% | 100.0 |  |
 | 123 | CHINOOK THERAPEUTICS INC. | | 24.02% | -18.0 |  |
 | 124 | LANDEC CORP \CA\ | | 23.26% | -24.0 |  |
 | 125 | Keros Therapeutics Inc. | | 21.69% | -57.0 |  |
 | 126 | BeiGene Ltd. | | 20.84% | 34.0 |  |
 | 127 | MARIZYME INC | | 18.52% | -77.0 |  |
 | 128 | Turning Point Therapeutics Inc. | | 16.87% | -76.0 |  |
 | 129 | RHYTHM PHARMACEUTICALS INC. | | 15.97% | 0.0 |  |
![]() | 130 | Olema Pharmaceuticals Inc. | | 15.67% | 0.0 |  |
 | 131 | HCW Biologics Inc. | | 14.65% | 0.0 |  |
![]() | 132 | Sensei Biotherapeutics Inc. | | 13.89% | 0.0 |  |
 | 133 | Amneal Pharmaceuticals Inc. | | 13.84% | -29.0 |  |
 | 134 | Merus N.V. | | 13.20% | 63.0 |  |
![]() | 135 | Kinnate Biopharma Inc. | | 12.89% | 0.0 |  |
![]() | 136 | Kura Oncology Inc. | | 8.50% | -77.0 |  |
![]() | 137 | Sio Gene Therapies Inc. | | 6.60% | 181.0 |  |
![]() | 138 | COMPASS Pathways plc | | 6.25% | 0.0 |  |
 | 139 | ARVINAS INC. | | 6.20% | -53.0 |  |
 | 140 | Petros Pharmaceuticals Inc. | | 5.27% | 0.0 |  |
 | 141 | Sage Therapeutics Inc. | | 3.81% | -138.0 |  |
![]() | 142 | Erasca Inc. | | 1.25% | 0.0 |  |
![]() | 143 | Longboard Pharmaceuticals Inc. | | 1.17% | 0.0 |  |
 | 144 | Reneo Pharmaceuticals Inc. | | 0.67% | 0.0 |  |
 | 145 | Lyell Immunopharma Inc. | | 0.46% | 0.0 |  |
![]() | 146 | Societal CDMO Inc. | | 0.08% | 48.0 |  |
![]() | 147 | Viking Therapeutics Inc. | | -2.00% | -82.0 |  |
![]() | 148 | CinCor Pharma Inc. | | -4.66% | 0.0 |  |
 | 149 | Morphic Holding Inc. | | -7.16% | -23.0 |  |
![]() | 150 | TYME TECHNOLOGIES INC. | | -9.57% | 0.0 |  |
![]() | 151 | Eliem Therapeutics Inc. | | -9.87% | 0.0 |  |
![]() | 152 | Silverback Therapeutics Inc. | | -10.62% | 0.0 |  |
 | 153 | Karuna Therapeutics Inc. | | -11.82% | -64.0 |  |
 | 154 | Ainos Inc. | | -12.80% | 233.0 |  |
![]() | 155 | Pyxis Oncology Inc. | | -14.07% | 0.0 |  |
 | 156 | Bausch Health Companies Inc. | | -14.13% | -37.0 |  |
 | 157 | Savara Inc | | -16.86% | 88.0 |  |
 | 158 | Y-mAbs Therapeutics Inc. | | -18.29% | 184.0 |  |
![]() | 159 | NANOVIRICIDES INC. | | -19.05% | 112.0 |  |
![]() | 160 | Ventyx Biosciences Inc. | | -21.73% | 0.0 |  |
 | 161 | NextCure Inc. | | -22.21% | -113.0 |  |
 | 162 | ARROWHEAD PHARMACEUTICALS INC. | | -24.19% | -77.0 |  |
 | 163 | ACADIA PHARMACEUTICALS INC | | -24.66% | 23.0 |  |
 | 164 | Xenetic Biosciences Inc. | | -25.29% | 171.0 |  |
 | 165 | Avidity Biosciences Inc. | | -25.29% | -104.0 |  |
 | 166 | Sarepta Therapeutics Inc. | | -25.32% | -15.0 |  |
 | 167 | F-star Therapeutics Inc. | | -28.59% | 37.0 |  |
 | 168 | DiaMedica Therapeutics Inc. | | -29.13% | 42.0 |  |
 | 169 | Mallinckrodt plc | | -29.29% | -19.0 |  |
 | 170 | NightHawk Biosciences Inc. | | -30.21% | -72.0 |  |
 | 171 | Terns Pharmaceuticals Inc. | | -31.55% | 0.0 |  |
![]() | 172 | IVERIC bio Inc. | | -32.79% | 19.0 |  |
 | 173 | Nurix Therapeutics Inc. | | -32.94% | -90.0 |  |
![]() | 174 | Werewolf Therapeutics Inc. | | -33.90% | 0.0 |  |
 | 175 | CHINA PHARMA HOLDINGS INC. | | -34.31% | -54.0 |  |
 | 176 | ALPINE IMMUNE SCIENCES INC. | | -36.85% | -37.0 |  |
 | 177 | Virpax Pharmaceuticals Inc. | | -37.03% | 0.0 |  |
 | 178 | Lexaria Bioscience Corp. | | -38.99% | 201.0 |  |
![]() | 179 | Annovis Bio Inc. | | -41.56% | 127.0 |  |
![]() | 180 | Transcode Therapeutics Inc. | | -41.92% | 0.0 |  |
 | 181 | Seres Therapeutics Inc. | | -42.07% | -14.0 |  |
![]() | 182 | IO Biotech Inc. | | -42.53% | 0.0 |  |
 | 183 | Salarius Pharmaceuticals Inc. | | -43.05% | -45.0 |  |
 | 184 | AYTU BIOPHARMA INC | | -43.34% | -92.0 |  |
 | 185 | Actinium Pharmaceuticals Inc. | | -45.13% | -21.0 |  |
 | 186 | LUMOS PHARMA INC. | | -45.99% | -156.0 |  |
 | 187 | Evolus Inc. | | -46.17% | 110.0 |  |
 | 188 | Cogent Biosciences Inc. | | -46.26% | -52.0 |  |
![]() | 189 | Decibel Therapeutics Inc. | | -48.23% | 0.0 |  |
![]() | 190 | Nkarta Inc. | | -49.66% | -67.0 |  |
 | 191 | NGM BIOPHARMACEUTICALS INC | | -51.00% | -34.0 |  |
![]() | 192 | Repare Therapeutics Inc. | | -52.02% | -99.0 |  |
 | 193 | SELECTA BIOSCIENCES INC | | -53.51% | 40.0 |  |
![]() | 194 | Hepion Pharmaceuticals Inc. | | -53.56% | 11.0 |  |
 | 195 | Cryoport Inc. | | -53.79% | -132.0 |  |
 | 196 | Acasti Pharma Inc. | | -53.91% | 0.0 |  |
 | 197 | Verona Pharma plc | | -55.78% | -39.0 |  |
 | 198 | ImmunoGen Inc. | | -57.15% | -65.0 |  |
![]() | 199 | Akouos Inc. | | -58.86% | -135.0 |  |
 | 200 | Goodness Growth Holdings Inc. | | -61.51% | 0.0 |  |
 | 201 | Travere Therapeutics Inc. | | -63.65% | -20.0 |  |
 | 202 | BELLICUM PHARMACEUTICALS INC | | -64.09% | -62.0 |  |
 | 203 | Foghorn Therapeutics Inc. | | -64.67% | -37.0 |  |
 | 204 | HARROW HEALTH INC. | | -65.78% | 0.0 |  |
 | 205 | NovaBay Pharmaceuticals Inc. | | -65.94% | 109.0 |  |
 | 206 | Aurinia Pharmaceuticals Inc. | | -68.40% | -99.0 |  |
 | 207 | Bolt Biotherapeutics Inc. | | -68.87% | 0.0 |  |
 | 208 | ROCKET PHARMACEUTICALS INC. | | -69.15% | -90.0 |  |
![]() | 209 | SPRUCE BIOSCIENCES INC. | | -70.02% | 0.0 |  |
 | 210 | LEAP THERAPEUTICS INC. | | -71.09% | 41.0 |  |
 | 211 | RAPT Therapeutics Inc. | | -72.08% | 7.0 |  |
![]() | 212 | Vincerx Pharma Inc. | | -72.98% | -130.0 |  |
 | 213 | Fulcrum Therapeutics Inc. | | -74.56% | 51.0 |  |
![]() | 214 | Synaptogenix Inc. | | -76.33% | 178.0 |  |
 | 215 | International Stem Cell CORP | | -77.93% | 40.0 |  |
 | 216 | ChemoCentryx Inc. | | -78.35% | -137.0 |  |
 | 217 | Orgenesis Inc. | | -78.74% | 184.0 |  |
![]() | 218 | Rain Therapeutics Inc. | | -79.73% | 0.0 |  |
 | 219 | Anixa Biosciences Inc | | -79.77% | 140.0 |  |
 | 220 | Celularity Inc | | -81.53% | 0.0 |  |
 | 221 | Sonoma Pharmaceuticals Inc. | | -82.38% | -90.0 |  |
![]() | 222 | Xilio Therapeutics Inc. | | -82.79% | 0.0 |  |
 | 223 | SYNLOGIC INC. | | -83.09% | -20.0 |  |
 | 224 | ALNYLAM PHARMACEUTICALS INC. | | -83.43% | -51.0 |  |
![]() | 225 | Dyne Therapeutics Inc. | | -83.45% | -156.0 |  |
 | 226 | Gain Therapeutics Inc. | | -83.87% | 0.0 |  |
![]() | 227 | Stoke Therapeutics Inc. | | -83.98% | -150.0 |  |
 | 228 | CYTOKINETICS INC | | -84.52% | -54.0 |  |
 | 229 | Pulmatrix Inc. | | -84.63% | 23.0 |  |
![]() | 230 | Prelude Therapeutics Inc | | -86.61% | -116.0 |  |
![]() | 231 | Oncorus Inc. | | -87.80% | 0.0 |  |
 | 232 | SCYNEXIS INC | | -88.76% | 29.0 |  |
 | 233 | Mirum Pharmaceuticals Inc. | | -89.11% | -18.0 |  |
 | 234 | AMICUS THERAPEUTICS INC. | | -91.20% | -44.0 |  |
 | 235 | Protagonist Therapeutics Inc | | -91.25% | -134.0 |  |
 | 236 | INTERCEPT PHARMACEUTICALS INC. | | -92.79% | 8.0 |  |
 | 237 | Mirati Therapeutics Inc. | | -92.86% | -127.0 |  |
 | 238 | VBI Vaccines Inc BC | | -94.46% | -126.0 |  |
![]() | 239 | Zentalis Pharmaceuticals Inc. | | -95.05% | -83.0 |  |
 | 240 | Magenta Therapeutics Inc. | | -95.45% | -12.0 |  |
 | 241 | PIERIS PHARMACEUTICALS INC. | | -99.53% | -41.0 |  |
 | 242 | Aclaris Therapeutics Inc. | | -99.71% | 63.0 |  |
![]() | 243 | Tonix Pharmaceuticals Holding Corp. | | -101.99% | 10.0 |  |
![]() | 244 | RenovoRx Inc. | | -102.08% | 0.0 |  |
 | 245 | Arbutus Biopharma Corp | | -103.13% | 0.0 |  |
 | 246 | BIO-PATH HOLDINGS INC | | -103.93% | 54.0 |  |
 | 247 | MEI Pharma Inc. | | -104.18% | -88.0 |  |
![]() | 248 | Corvus Pharmaceuticals Inc. | | -106.60% | -201.0 |  |
![]() | 249 | Kronos Bio Inc. | | -106.80% | -161.0 |  |
 | 250 | Matinas BioPharma Holdings Inc. | | -107.03% | -101.0 |  |
 | 251 | Advaxis Inc. | | -108.81% | 53.0 |  |
 | 252 | Cure Pharmaceutical Holding Corp. | | -110.22% | 0.0 |  |
 | 253 | DURECT CORP | | -111.95% | -229.0 |  |
 | 254 | Liquidia Corp | | -112.28% | 35.0 |  |
 | 255 | AVADEL PHARMACEUTICALS PLC | | -112.30% | -197.0 |  |
![]() | 256 | NeuBase Therapeutics Inc. | | -117.65% | -13.0 |  |
![]() | 257 | AMERICAN BIO MEDICA CORP | | -123.91% | -20.0 |  |
 | 258 | Regulus Therapeutics Inc. | | -128.00% | -47.0 |  |
![]() | 259 | MANNKIND CORP | | -131.24% | -1.0 |  |
 | 260 | Landos Biopharma Inc. | | -134.03% | 0.0 |  |
 | 261 | ATAI Life Sciences N.V. | | -134.95% | 0.0 |  |
 | 262 | Emmaus Life Sciences Inc. | | -135.16% | -147.0 |  |
 | 263 | 2seventy bio Inc. | | -136.61% | 0.0 |  |
 | 264 | EYENOVIA INC. | | -137.06% | 11.0 |  |
![]() | 265 | Immunome Inc. | | -139.88% | -72.0 |  |
 | 266 | FIBROGEN INC | | -140.28% | -122.0 |  |
 | 267 | PLIANT THERAPEUTICS INC. | | -144.85% | -211.0 |  |
 | 268 | Monopar Therapeutics | | -145.82% | -86.0 |  |
 | 269 | Altimmune Inc. | | -146.80% | -173.0 |  |
 | 270 | BioXcel Therapeutics Inc. | | -147.98% | -90.0 |  |
 | 271 | Fortress Biotech Inc. | | -148.37% | -93.0 |  |
 | 272 | Corbus Pharmaceuticals Holdings Inc. | | -149.51% | 74.0 |  |
 | 273 | Xeris Biopharma Holdings Inc. | | -153.30% | 0.0 |  |
 | 274 | Paratek Pharmaceuticals Inc. | | -153.56% | -11.0 |  |
![]() | 275 | Genprex Inc. | | -153.68% | 2.0 |  |
![]() | 276 | Ampio Pharmaceuticals Inc. | | -156.11% | 31.0 |  |
![]() | 277 | Inozyme Pharma Inc. | | -159.15% | -115.0 |  |
 | 278 | Homology Medicines Inc. | | -159.34% | -39.0 |  |
 | 279 | RVL Pharmaceuticals plc | | -161.04% | -110.0 |  |
![]() | 280 | CymaBay Therapeutics Inc. | | -161.36% | -119.0 |  |
![]() | 281 | Equillium Inc. | | -163.12% | -102.0 |  |
![]() | 282 | Immune Therapeutics Inc. | | -165.05% | 11.0 |  |
![]() | 283 | Molecular Templates Inc. | | -166.06% | 27.0 |  |
 | 284 | Frequency Therapeutics Inc. | | -166.83% | -206.0 |  |
 | 285 | Verrica Pharmaceuticals Inc. | | -167.06% | 0.0 |  |
![]() | 286 | Vicapsys Life Sciences Inc. | | -167.22% | 68.0 |  |
 | 287 | Novan Inc. | | -167.89% | 0.0 |  |
 | 288 | Karyopharm Therapeutics Inc. | | -171.55% | 2.0 |  |
![]() | 289 | Applied Molecular Transport Inc. | | -171.86% | -59.0 |  |
![]() | 290 | Oncotelic Therapeutics Inc. | | -172.65% | 0.0 |  |
 | 291 | Acer Therapeutics Inc. | | -173.27% | 87.0 |  |
 | 292 | NEKTAR THERAPEUTICS | | -177.91% | -129.0 |  |
 | 293 | CHEMBIO DIAGNOSTICS INC. | | -179.93% | -81.0 |  |
 | 294 | SOLIGENIX INC. | | -181.45% | 28.0 |  |
![]() | 295 | Radius Health Inc. | | -182.81% | -28.0 |  |
 | 296 | CONCERT PHARMACEUTICALS INC. | | -184.61% | 0.0 |  |
![]() | 297 | America Great Health | | -187.53% | 32.0 |  |
![]() | 298 | Forte Biosciences Inc. | | -188.32% | 0.0 |  |
 | 299 | ACELRX PHARMACEUTICALS INC | | -189.88% | -25.0 |  |
![]() | 300 | Rezolute Inc. | | -189.97% | 89.0 |  |
 | 301 | Unity Biotechnology Inc. | | -190.80% | -18.0 |  |
![]() | 302 | ZOGENIX INC. | | -191.62% | -117.0 |  |
![]() | 303 | Arcutis Biotherapeutics Inc. | | -197.01% | -79.0 |  |
 | 304 | CytomX Therapeutics Inc. | | -197.40% | -172.0 |  |
![]() | 305 | Gemini Therapeutics Inc. DE | | -197.99% | 0.0 |  |
 | 306 | Blueprint Medicines Corp | | -201.47% | -300.0 |  |
 | 307 | AVEO PHARMACEUTICALS INC. | | -201.58% | -51.0 |  |
 | 308 | OptiNose Inc. | | -202.35% | -51.0 |  |
 | 309 | Aptevo Therapeutics Inc. | | -203.95% | -114.0 |  |
 | 310 | GERON CORP | | -204.43% | -169.0 |  |
 | 311 | Arcturus Therapeutics Holdings Inc. | | -206.63% | -221.0 |  |
 | 312 | Spero Therapeutics Inc. | | -210.58% | -65.0 |  |
![]() | 313 | MUSTANG BIO INC. | | -211.43% | -48.0 |  |
 | 314 | Cue Biopharma Inc. | | -211.76% | 0.0 |  |
 | 315 | Theravance Biopharma Inc. | | -213.15% | -31.0 |  |
 | 316 | Revance Therapeutics Inc. | | -214.69% | -107.0 |  |
 | 317 | LANNETT CO INC | | -215.89% | -214.0 |  |
 | 318 | OTONOMY INC. | | -216.18% | -101.0 |  |
 | 319 | INFINITY PHARMACEUTICALS INC. | | -216.26% | 2.0 |  |
 | 320 | Sigilon Therapeutics Inc. | | -216.49% | 0.0 |  |
 | 321 | IntelGenx Technologies Corp. | | -216.63% | -33.0 |  |
 | 322 | Akebia Therapeutics Inc. | | -218.39% | -42.0 |  |
![]() | 323 | AILERON THERAPEUTICS INC | | -218.45% | 48.0 |  |
 | 324 | Zymeworks Inc. | | -221.51% | -149.0 |  |
 | 325 | Atreca Inc. | | -223.05% | -171.0 |  |
![]() | 326 | IMARA Inc. | | -225.21% | -105.0 |  |
 | 327 | Clovis Oncology Inc. | | -225.22% | -49.0 |  |
 | 328 | Histogen Inc. | | -225.82% | 30.0 |  |
 | 329 | BridgeBio Pharma Inc. | | -227.26% | -38.0 |  |
 | 330 | ORAGENICS INC | | -231.22% | 0.0 |  |
![]() | 331 | NexImmune Inc. | | -232.99% | 0.0 |  |
 | 332 | Angion Biomedica Corp. | | -235.73% | 0.0 |  |
![]() | 333 | RELMADA THERAPEUTICS INC. | | -236.14% | -91.0 |  |
![]() | 334 | CohBar Inc. | | -239.18% | 0.0 |  |
![]() | 335 | Praxis Precision Medicines Inc. | | -240.67% | 0.0 |  |
 | 336 | Aravive Inc. | | -241.04% | -107.0 |  |
 | 337 | Wave Life Sciences Ltd. | | -242.12% | -78.0 |  |
 | 338 | G1 Therapeutics Inc. | | -243.75% | -122.0 |  |
 | 339 | Intra-Cellular Therapies Inc. | | -247.56% | -193.0 |  |
 | 340 | Timber Pharmaceuticals Inc. | | -253.83% | 35.0 |  |
 | 341 | PLx Pharma Inc. | | -256.72% | -71.0 |  |
 | 342 | Aeglea BioTherapeutics Inc. | | -257.35% | -101.0 |  |
 | 343 | MACROGENICS INC | | -258.60% | -166.0 |  |
 | 344 | YUMANITY THERAPEUTICS INC. | | -262.85% | -96.0 |  |
 | 345 | Minerva Neurosciences Inc. | | -265.05% | -335.0 |  |
 | 346 | Zosano Pharma Corp | | -267.14% | -112.0 |  |
 | 347 | Esperion Therapeutics Inc. | | -272.73% | -116.0 |  |
 | 348 | ROCKWELL MEDICAL INC. | | -274.55% | -135.0 |  |
![]() | 349 | SANGUI BIOTECH INTERNATIONAL INC | | -275.71% | -46.0 |  |
 | 350 | LEXICON PHARMACEUTICALS INC. | | -288.79% | -202.0 |  |
![]() | 351 | Larimar Therapeutics Inc. | | -289.99% | -153.0 |  |
 | 352 | TREVENA INC | | -292.25% | -232.0 |  |
 | 353 | Benitec Biopharma Inc. | | -293.12% | -37.0 |  |
 | 354 | Biohaven Pharmaceutical Holding Co Ltd. | | -295.54% | -24.0 |  |
 | 355 | Biofrontera Inc. | | -295.78% | 0.0 |  |
 | 356 | Aptinyx Inc. | | -295.79% | -204.0 |  |
 | 357 | Verastem Inc. | | -297.15% | -138.0 |  |
![]() | 358 | Cellectar Biosciences Inc. | | -297.82% | -241.0 |  |
![]() | 359 | GALECTIN THERAPEUTICS INC | | -298.78% | -31.0 |  |
![]() | 360 | Aprea Therapeutics Inc. | | -302.25% | -87.0 |  |
![]() | 361 | ENDONOVO THERAPEUTICS INC. | | -302.77% | -125.0 |  |
 | 362 | HERON THERAPEUTICS INC. DE | | -303.90% | -68.0 |  |
![]() | 363 | IMMUNIC INC. | | -304.06% | 0.0 |  |
 | 364 | vTv Therapeutics Inc. | | -309.26% | -44.0 |  |
 | 365 | Athenex Inc. | | -310.31% | 0.0 |  |
 | 366 | MARINUS PHARMACEUTICALS INC. | | -310.81% | 0.0 |  |
![]() | 367 | Kiniksa Pharmaceuticals Ltd. | | -312.01% | -140.0 |  |
 | 368 | GLYCOMIMETICS INC | | -313.44% | -192.0 |  |
 | 369 | Dare Bioscience Inc. | | -314.59% | 0.0 |  |
 | 370 | Deciphera Pharmaceuticals Inc. | | -318.48% | -168.0 |  |
![]() | 371 | Dermata Therapeutics Inc. | | -319.10% | 0.0 |  |
 | 372 | ASSEMBLY BIOSCIENCES INC. | | -320.55% | -263.0 |  |
 | 373 | MusclePharm Corp | | -320.98% | -220.0 |  |
![]() | 374 | Phathom Pharmaceuticals Inc. | | -329.17% | -148.0 |  |
 | 375 | Aadi Bioscience Inc. | | -332.45% | -336.0 |  |
 | 376 | Evoke Pharma Inc | | -349.65% | -27.0 |  |
 | 377 | 9 METERS BIOPHARMA INC. | | -352.59% | 0.0 |  |
 | 378 | IMPEL PHARMACEUTICALS INC | | -353.03% | 0.0 |  |
 | 379 | CV Sciences Inc. | | -363.63% | -78.0 |  |
 | 380 | Aquestive Therapeutics Inc. | | -365.55% | -72.0 |  |
 | 381 | Summit Therapeutics Inc. | | -369.25% | -132.0 |  |
 | 382 | TherapeuticsMD Inc. | | -371.27% | -65.0 |  |
![]() | 383 | REGENERX BIOPHARMACEUTICALS INC | | -372.50% | -40.0 |  |
 | 384 | SEELOS THERAPEUTICS INC. | | -374.01% | -43.0 |  |
 | 385 | Qualigen Therapeutics Inc. | | -374.08% | 0.0 |  |
![]() | 386 | ONCOSEC MEDICAL Inc | | -380.31% | -22.0 |  |
 | 387 | UroGen Pharma Ltd. | | -381.93% | -34.0 |  |
 | 388 | SELLAS Life Sciences Group Inc. | | -382.92% | 0.0 |  |
 | 389 | Mersana Therapeutics Inc. | | -383.18% | -221.0 |  |
 | 390 | Alaunos Therapeutics Inc. | | -388.64% | -124.0 |  |
 | 391 | TFF Pharmaceuticals Inc. | | -391.04% | -159.0 |  |
![]() | 392 | Metacrine Inc. | | -394.58% | -221.0 |  |
![]() | 393 | ARENA PHARMACEUTICALS INC | | -402.92% | -228.0 |  |
 | 394 | Vaxxinity Inc. | | -405.86% | 0.0 |  |
![]() | 395 | Skye Bioscience Inc. | | -406.61% | -4.0 |  |
 | 396 | Innovation1 Biotech Inc. | | -413.73% | -115.0 |  |
 | 397 | EXICURE INC. | | -418.67% | -255.0 |  |
 | 398 | KIORA PHARMACEUTICALS INC | | -420.88% | -138.0 |  |
 | 399 | CNBX Pharmaceuticals Inc. | | -423.69% | 7.0 |  |
 | 400 | Sonnet BioTherapeutics Holdings Inc. | | -430.75% | 0.0 |  |
 | 401 | ABVC BIOPHARMA INC. | | -440.35% | -78.0 |  |
 | 402 | TG THERAPEUTICS INC. | | -441.45% | -182.0 |  |
![]() | 403 | Rasna Therapeutics Inc. | | -444.51% | 1.0 |  |
 | 404 | Cyclerion Therapeutics Inc. | | -444.83% | -102.0 |  |
![]() | 405 | Nascent Biotech Inc. | | -446.74% | -5.0 |  |
 | 406 | Epizyme Inc. | | -449.66% | 0.0 |  |
![]() | 407 | Sierra Oncology Inc. | | -454.17% | -83.0 |  |
 | 408 | Innovation Pharmaceuticals Inc. | | -455.79% | -41.0 |  |
![]() | 409 | RespireRx Pharmaceuticals Inc. | | -456.14% | -47.0 |  |
 | 410 | CytoDyn Inc. | | -456.62% | -27.0 |  |
 | 411 | Jaguar Health Inc. | | -460.76% | -96.0 |  |
 | 412 | Avalo Therapeutics Inc. | | -461.87% | -38.0 |  |
![]() | 413 | Greater Cannabis Company Inc. | | -471.90% | -17.0 |  |
![]() | 414 | Hillstream BioPharma Inc. | | -476.11% | 0.0 |  |
 | 415 | Iterum Therapeutics plc | | -476.70% | -75.0 |  |
 | 416 | Checkpoint Therapeutics Inc. | | -483.07% | -154.0 |  |
![]() | 417 | PROVECTUS BIOPHARMACEUTICALS INC. | | -483.28% | -92.0 |  |
![]() | 418 | NeuroBo Pharmaceuticals Inc. | | -484.36% | -16.0 |  |
 | 419 | ARDELYX INC. | | -507.60% | -184.0 |  |
![]() | 420 | Wellness Center USA Inc. | | -516.61% | -34.0 |  |
![]() | 421 | Regen BioPharma Inc | | -531.76% | -392.0 |  |
![]() | 422 | InMed Pharmaceuticals Inc. | | -532.36% | 0.0 |  |
 | 423 | ABEONA THERAPEUTICS INC. | | -535.01% | -155.0 |  |
![]() | 424 | Acurx Pharmaceuticals Inc. | | -540.56% | 0.0 |  |
![]() | 425 | REGENEREX PHARMA INC. | | -550.20% | -179.0 |  |
 | 426 | CTI BIOPHARMA CORP | | -557.57% | -89.0 |  |
 | 427 | VYNE Therapeutics Inc. | | -571.56% | -28.0 |  |
![]() | 428 | Virios Therapeutics Inc. | | -572.91% | 0.0 |  |
![]() | 429 | Vallon Pharmaceuticals Inc. | | -578.22% | 0.0 |  |
![]() | 430 | Evelo Biosciences Inc. | | -582.37% | 0.0 |  |
 | 431 | One World Products Inc. | | -609.11% | -26.0 |  |
![]() | 432 | IGM Biosciences Inc. | | -610.55% | 0.0 |  |
![]() | 433 | Applied Therapeutics Inc. | | -613.87% | -94.0 |  |
 | 434 | Guardion Health Sciences Inc. | | -616.79% | -96.0 |  |
![]() | 435 | HST Global Inc. | | -619.59% | -37.0 |  |
 | 436 | Entasis Therapeutics Holdings Inc. | | -620.44% | -105.0 |  |
 | 437 | Ensysce Biosciences Inc. | | -621.12% | 0.0 |  |
 | 438 | Adamis Pharmaceuticals Corp | | -621.50% | -73.0 |  |
![]() | 439 | Cell Source Inc. | | -631.87% | -78.0 |  |
 | 440 | SPECTRUM PHARMACEUTICALS INC | | -676.97% | -113.0 |  |
 | 441 | ATHERSYS INC NEW | | -710.51% | -78.0 |  |
![]() | 442 | ARTELO BIOSCIENCES INC. | | -714.42% | -86.0 |  |
![]() | 443 | BIORA THERAPEUTICS INC. | | -725.56% | -109.0 |  |
![]() | 444 | CANNAPHARMARX INC. | | -762.19% | -76.0 |  |
![]() | 445 | Hoth Therapeutics Inc. | | -780.56% | 0.0 |  |
![]() | 446 | LIXTE BIOTECHNOLOGY HOLDINGS INC. | | -817.17% | -151.0 |  |
![]() | 447 | Propanc Biopharma Inc. | | -825.23% | -53.0 |  |
 | 448 | AGILE THERAPEUTICS INC | | -846.97% | -139.0 |  |
 | 449 | CEN BIOTECH INC | | -848.36% | -445.0 |  |
 | 450 | NEUROPATHIX INC. | | -848.93% | 0.0 |  |
![]() | 451 | Immix Biopharma Inc. | | -861.39% | 0.0 |  |
 | 452 | CATALYST BIOSCIENCES INC. | | -887.93% | -166.0 |  |
![]() | 453 | Earth Science Tech Inc. | | -904.78% | -65.0 |  |
![]() | 454 | Anebulo Pharmaceuticals Inc. | | -906.80% | 0.0 |  |
 | 455 | MADRIGAL PHARMACEUTICALS INC. | | -912.49% | -78.0 |  |
 | 456 | Coeptis Therapeutics Inc. | | -930.52% | 0.0 |  |
 | 457 | CHIMERIX INC | | -946.04% | -203.0 |  |
![]() | 458 | Alzamend Neuro Inc. | | -958.75% | 0.0 |  |
 | 459 | Astria Therapeutics Inc. | | -989.78% | 0.0 |  |
![]() | 460 | Evofem Biosciences Inc. | | -1010.06% | 0.0 |  |
 | 461 | Calithera Biosciences Inc. | | -1027.68% | -148.0 |  |
![]() | 462 | Bioquest Corp | | -1184.80% | 0.0 |  |
 | 463 | HUMANIGEN INC | | -1190.34% | -97.0 |  |
![]() | 464 | Q BioMed Inc. | | -1224.89% | -57.0 |  |
![]() | 465 | BIOXYTRAN INC | | -1286.97% | -84.0 |  |
 | 466 | VACCINEX INC. | | -1347.72% | -86.0 |  |
 | 467 | Ocuphire Pharma Inc. | | -1374.65% | 0.0 |  |
 | 468 | Aditxt Inc. | | -1529.95% | -157.0 |  |
![]() | 469 | First Wave BioPharma Inc. | | -1569.95% | -87.0 |  |
 | 470 | Brooklyn ImmunoTherapeutics Inc. | | -1677.33% | -122.0 |  |
![]() | 471 | Scopus BioPharma Inc. | | -1700.11% | -68.0 |  |
![]() | 472 | ProtoKinetix Inc. | | -3361.89% | -64.0 |  |
![]() | 473 | GlobeStar Therapeutics Corp | | -11004.70% | -104.0 |  |
![]() | 474 | BIOVIE INC. | | -14858.80% | -102.0 |  |
![]() | 475 | NEXIEN BIOPHARMA INC. | | -23332.90% | -66.0 |  |